Ba. Merrick et al., HSP BINDING AND MITOCHONDRIAL LOCALIZATION OF P53 PROTEIN IN HUMAN HT1080 AND MOUSE C3H10T1 2 CELL-LINES/, Biochimica et biophysica acta. Protein structure and molecular enzymology, 1297(1), 1996, pp. 57-68
In normal cells, the tumor suppressor actions of p53 protein are media
ted by specific DNA binding and protein-protein interactions within th
e nucleus. Mutant p53 proteins, however, often assume an aberrant conf
ormation devoid of tumor suppressor activity and newly capable of bind
ing to the cognate or inducible HSP70. Recent reports from our laborat
ory and others show that additional unknown proteins may also complex
with mutant p53. In this study, we characterize p53:HSP complexes and
their subcellular location in the transformed cell lines, human HT1080
and murine C3H10T1/2, which both contain aberrant p53 conformers. Imm
unoprecipitation and SDS-PAGE of p53 from whole cell lysates revealed
the additional presence of a broad 70 kDa band and a 90 kDa band in bo
th lines, while p53 isolated from nuclear lysates was free from other
proteins. 2D-PAGE was used to isolate and identify HSP members from cy
toplasmic and nuclear lysates by immunoprecipitation, Western blotting
and protein sequencing. Anti-p53 immune complexes from cytoplasmic ly
sates contained not only HSC70 but also GRP75, GRP78 and a weakly basi
c 90 kDa protein, which may be related to HSP90. The inducible form of
HSP70 was not complexed to p53 protein, even though expressed in thes
e cells. Analysis of anti-HSP70, anti-GRP75 and anti-HSP90 immune comp
lexes suggests that HSP members exist as preformed complexes in the cy
toplasm, but not the nucleus. The presence of the mitochondrial and en
doplasmic reticular chaperones, GRP75 and GRP78. in p53:HSP complexes
suggested that p53 might be found in these cytoplasmic organelles whic
h was confirmed in mitochondria by biochemical and immunoelectron micr
oscopic evidence. These studies suggest that newly identified members
of p53:HSP complexes represent components of a chaperone program which
affects the subcellular distribution of p53 protein in these transfor
med lines.